arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

LEXICON PHARMACEUTICALS, INC.

LXRX

$2.46 ▲ +0.10 (+4.47%) at close

18 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

LEXICON PHARMACEUTICALS, INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $893.1M

Dividend Yield —

Revenue Growth 60.2% ↘

Op. Margin -98.2%

ROIC -24.6% ↗

FCF / Share $-0.19 ↗

Trailing P/E —

Price / Book 8.4x

FCF Yield —

Debt / Equity 0.46

info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$49.80M

↑ +60.2% —

Net Income Profit after all expenses

$-50.34M

↑ +74.9% —

Operating Margin Operating profit as % of sales

-98.2%

↑ +50.7% 2th

FCF / Share Free cash flow per share

$-0.19

↑ +66.7% —

Long-Term Debt Long-term obligations

$49.41M

↓ -50.7% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	60.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+653%)	2481.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+30918%)	766.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+9477%)	-53.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-767%)	-98.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1334%)	-92.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1257%)	409.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5019%)	-31.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-488%)	10.0% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+25%)	-35.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-549%)	468.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5761%)	928.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+11507%)	104.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1201%)	-41.1% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-614%)	-62.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-879%)	-54.1% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-777%)	—	—
EPS Growth YoY (%)	77.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	21.3% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-29.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-3.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-13.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	74.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-13.1% Weak ↑ Weak Improving Year-over-year change in net income	-73.7% Weak ↓ Weak Declining Year-over-year change in net income	-16.2% Weak Weak Year-over-year change in net income	-49.8% Weak Weak Year-over-year change in net income	N/M	N/M	2.0% Caution ↑ Caution Improving Year-over-year change in net income	13.0% Fair ↑ Fair Improving Year-over-year change in net income	-2920.7% Weak ↓ Weak Declining Year-over-year change in net income	95.3% Excellent ↑ Excellent Improving Year-over-year change in net income	3.7% Caution ↑ Caution Improving Year-over-year change in net income	5.5% Fair ↑ Fair Improving Year-over-year change in net income	5.2% Fair ↑ Fair Improving Year-over-year change in net income	-14.2% Weak Weak Year-over-year change in net income	-22.9% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	66.7% Excellent Excellent Year-over-year change in free cash flow	23.5% Good Good Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	610.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	370.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-63.1% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-92.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-83.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-36.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	56.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	-21.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	58.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	234.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	392.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	131.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-23.2% Weak Weak Compound annual revenue growth over 3 years	-53.3% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	15.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-37.4% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-54.7% Weak → Weak Stable Compound annual revenue growth over 5 years	-72.7% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-67.6% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-28.7% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	69.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	95.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	142.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	114.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	92.6% Excellent Excellent Compound annual revenue growth over 5 years	16.4% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Operating Margin (%) (%)	-98.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-755%)	—	—	—	—	-199.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1428%)	43.9% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+193%)	-163.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1189%)	-142.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1050%)	-164.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1197%)	1.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-92%)	-439.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3028%)	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-101.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-942%)	—	—	—	—	-244.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2134%)	40.4% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+237%)	-190.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1689%)	-134.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1218%)	-169.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1514%)	-3.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-130%)	-438.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3757%)	—	—	—	—	—	—
FCF Margin (%) (%)	-136.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	35.3% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-235.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-202.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-211.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	141.4% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	-331.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—
FCF / Net Income (x)	1.35x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	2.44x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.23x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.51x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.24x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	-39.27x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Invested Capital (%)	-24.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-63.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-70.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-48.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-60.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	30.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-37.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-56.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	0.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-25.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-53.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-37.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-34.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-26.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-66.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-74.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-51.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-63.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	33.9% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-36.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	0.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-37.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-26.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-46.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-412%)	-137.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1015%)	-190.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1368%)	-87.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-680%)	-77.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-615%)	-37.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-350%)	111.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+641%)	—	-180.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1301%)	-89.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-699%)	-1.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-111%)	-35.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-335%)	-61.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-508%)	-41.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-376%)	-39.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-360%)	-41.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-375%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Debt to Equity (x)	0.46x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-23%)	0.69x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+15%)	1.07x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+78%)	0.41x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-31%)	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	2.12x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+254%)	-9.24x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-1639%)	3.39x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+465%)	0.54x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-10%)	0.37x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-38%)	0.38x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-37%)	0.12x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-80%)	0.09x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-85%)	0.08x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-87%)	0.11x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-82%)	—	—
Interest Coverage (x)	-5.87x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-15.26x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-17.08x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-36.24x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-108.59x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3.29x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	6.84x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	-4.97x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-18.70x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-20.89x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	0.22x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-44.55x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-51.94x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-51.28x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-45.13x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-35.20x Weak Weak Operating income divided by interest expense Optimal: > 5x	-30.33x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$15.08M	$33.64M	$77.04M	$2.25M	$-64.06M	$-126.26M	$212.52M	$163.50M	$169.91M	$38.57M	$-97.18M	$-29.60M	$-17.33M	$-6.97M	$-162.86M	$-19.86M	$-100.55M	$-85.87M
Debt / EBITDA (x)	-1.02x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.51x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.58x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.48x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	1.71x Good ↑ Good Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.45x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.82x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.63x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	48.20x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.09x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.20x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.23x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.21x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.30x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue per Share (USD)	$0.14	$0.10	$0.01	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.14	$-0.63	$-0.80	$-0.62	$-0.60	$-0.53	$1.23	$-1.14	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.19	$-0.56	$-0.73	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.29	$0.40	$0.42	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$0.17	$0.28	$0.22	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	363.05M	320.03M	221.13M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Working Capital (USD)	$81.03M	$200.94M	$145.00M	$117.69M	$66.80M	$110.91M	$272.41M	$136.57M	$216.51M	$193.23M	$409.40M	$324.02M	$115.26M	$212.65M	$264.40M	$203.96M	—	—
LT Debt (USD)	$49.41M	$100.30M	$99.51M	$48.60M	$0.00	$0.00	$248.63M	$243.89M	$231.58M	$85.17M	$105.81M	$107.67M	$20.17M	$23.45M	$23.45M	$27.34M	—	—
Total Equity (USD)	$107.54M	$145.95M	$93.11M	$117.12M	$113.59M	$156.37M	$117.10M	$-26.41M	$68.27M	$157.40M	$285.85M	$284.02M	$170.16M	$266.68M	$297.57M	$247.02M	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	$49.80M	$31.08M	$1.20M	$139.00K	$298.00K	$24.00M	$322.07M	$63.21M	$91.69M	$83.34M	$130.01M	$22.85M	$2.22M	$1.09M	$1.85M	$4.91M	$10.70M	—
Depreciation Expense (USD)	$621.00K	$534.00K	$554.00K	$427.00K	$292.00K	$2.93M	$3.65M	$3.68M	$3.40M	$2.06M	$727.00K	$1.93M	$2.86M	$4.19M	$4.89M	$5.39M	$6.16M	—
Net Income, GAAP (USD)	$-50.34M	$-200.40M	$-177.12M	$-101.94M	$-87.76M	$-58.57M	$130.13M	$-120.55M	$-122.99M	$-141.43M	$-4.68M	$-100.29M	$-104.13M	$-110.21M	$-116.22M	$-101.78M	$-82.78M	—
Operating Cash Flow (USD)	$-67.85M	$-178.78M	$-161.90M	$-88.85M	$-87.02M	$-142.97M	$113.81M	$-148.61M	$-185.39M	$-175.63M	$184.78M	$-75.62M	$-91.08M	$-94.46M	$-87.94M	$-82.37M	$-89.02M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters

LEXICON PHARMACEUTICALS, INC.

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare LXRX with peers